INTRODUCTION
Secondary hyperparathyroidism (sHPT) is a common complication of chronic kidney disease (CKD), and is characterized by persistently elevated levels of parathyroid hormone (PTH) and parathyroid hyperplasia. It develops early in the course of CKD as an adaptive response to altered mineral homeostasis due to decreased kidney functions such as hyperphosphatemia, hypocalcemia, and 1,25(OH)2D deficiency [1] . Early stages of sHPT can be treated medically with the use of calcium supplementation, vitamin D analogues, phosphate binders, a low phosphate diet, and calcimimetic agents, whereas more advanced stages often require surgery. Indications for paraWoo Young Kim, et al.
thesurgery.or.kr thyroidectomy are medical treatment failure of severe sHPT resulting in excessive PTH and uncontrollable calcium/phosphate products, clinical signs such as pruritus and bone pain, biopsy-proven hyperparathyroid bone disease, pathological fractures, and calciphylaxis [2] . Surgical treatment is recommended in 0.5 to 2.6% of patients with sHPT [3, 4] . The practice of parathyroidectomy in sHPT is well-established, and subtotal parathyroidectomy with the goal of retaining some parathyroid function has been preferentially performed [4] . Critics of subtotal parathyroidectomy quote high recurrence rates that approach 30% [5] . More recently, total parathyroidectomy has attracted increased interest [3] , although no consensus view has emerged as to which approach is best. Intraoperative parathyroid hormone (ioPTH) measurement is a functional diagnostic tool during parathyroid surgery that permits prediction of postoperative outcome and helps the surgeon to decide whether further exploration is necessary [6] . A reduction in ioPTH levels of ≥50% indicates surgical success with a sensitivity of 98% and specificity of 91% in primary hyperparathyroidism, and has been suggested as appropriate for ioPTH monitoring in surgical treatment of sHPT [4, [6] [7] [8] [9] [10] . Nonetheless, there is no standard definition of success in sHPT. The aim of our study was to establish which criterion of ioPTH decline performs best and to assess the efficacy of ioPTH monitoring in predicting postoperative outcome in patients with sHPT.
METHODS
For this study, we analyzed the outcomes of 102 operations for sHPT guided by ioPTH assays performed at Korea University Guro Hospital between January 2003 and October 2010. All patients with sHPT had chronic renal failure as the underlying disease leading to HPT and received hemodialysis. Twenty-two patients were lost to follow-up. Thus, 80 patients were enrolled. Informed consent was obtained from all patients. We performed radiologic imaging studies such as sestamibi scans, ultrasonography, and computed tomography for most patients preoperatively. For patients undergoing surgery for the first time, surgery was performed by exploration of the neck, initially focusing at the usual anatomic sites that harbor the upper and lower parathyroid glands bilaterally. If supernumerary glands were discovered during this dissection, these were also excised. All excised specimens from suspected supernumerary glands were identified as parathyroid glands by frozen section biopsy. However, if fewer than four parathyroid glands were located during this process, the search for the remaining parathyroid Differences between ROC curves were tested with a boot- Biochemical definition defined as a serum PTH concentration equal to or below 300 pg/mL for successful operation was used.
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Values are presented as mean. 
RESULTS
During the study period, 81 surgical total parathy- Box and whiskers plot of parathyroid hormone (PTH) assays for all patients who underwent a parathyroidectomy during the study period. Intraoperative PTH (ioPTH), ioPTH2, and ioPTH3 were performed perioperatively; PTH assays were performed at the 1-year follow-up. ioPTH1, baseline levels of ioPTH; ioPTH2, ioPTH levels at 20 minutes after excision; ioPTH3, ioPTH levels at 40 minutes after excision. 3 . Receiver operating characteristic curves from the percentage decline based on the ioPTH2 and ioPTH3 assay results. ioPTH2, ioPTH levels at 20 minutes after excision; ioPTH3, ioPTH levels at 40 minutes after excision.
percentage reduction was 89.4% (range, 53.9 to 98.0%) for group 1 patients, which was considered physiologically acceptable, and 84.7% (range, 64.0 to 96.0%) for group 2 patients, which was considered as a failure. The range and interquartile range are shown as a box and whisker plot for each group in Fig. 2 . A significant difference in the percentage of ioPTH decline was evident between the successful and unsuccessful operations for both ioPTH2 and ioPTH3 (Table 1) . Furthermore, serum phosphate concentrations differed significantly at one year between the two groups. We next assessed the percentage of PTH decline that was most accurate at predicting postoperative success. When different percentages of ioPTH decline were considered, the ROC curves for the percentage decline using ioPTH2 were slightly, but not significantly, less accurate than the ROC curves based on ioPTH3 values ( Fig. 3 ; n = 80 without any missing values, difference in area under the curve 0.051 with a confidence interval of -0.074 to 0.177). Given these slightly better ratios for sensitivity and specificity based on ioPTH3 data and the goal of maintaining sensitivity (approximately 86%), the criterion of a 85% decline in ioPTH2 as the cut-off point resulted in the best ratio with a sensitivity of 86% and a specificity of 60% (Fig. 3) . However, this did not differ significantly from the best ratio of ioPTH2 (75% decline), with a sensitivity of 83% and specificity of 48%. 
DISCUSSION
At the 1-year follow-up, we found that 71.3% of the operations had yielded a physiologically acceptable cure, defined as a PTH level ≤300 pg/mL. This result seems rather good, even in light of literature reporting a 35% chance of persistent or recurrent disease for patients with sHPT [11] [12] [13] ; however, our criterion for cure might be different.
We categorized patients into two groups -a physiologically acceptable group and a surgically failed groupbased on a PTH level of 300 pg/mL. The ideal blood concentration of PTH is not known for uremic subjects, but the levels advocated by different researchers vary from 75 to 175 pg/mL [10] . [4, 6, 9] . When using the intact PTH assay, several authors have suggested using the same criterion as that used in patients with primary hyperparathyroidism (the Miami Criterion of ＞50% decline from baseline PTH 5 to 10 minutes after excision) [7, 15] , whereas other authors argued that higher percentages of decline or absolute values at other time points after excision are necessary [9] . Given that in the present series of patients the reduction in ioPTH was well over 50% in all patients, yet 28.7%
of patients were subsequently categorized as surgical failures, the 50% rule for ioPTH reduction has no relevance in the surgical management of sHPT. We analyzed the ROC optimal criterion than patients with renal transplants with a mild-to-moderate degree of renal failure. Fig. 2 shows that the ioPTH data for the two outcome groups differed significantly. These data and the scatterplot data (Fig. 4) collectively suggest that the greater the reduction in ioPTH, the greater the chance of a surgical cure. However, it remains unclear why some patients with similar levels of reduction of ioPTH and histologic evidence of a successfully performed parathyroidectomy ultimately fall into different outcome groups. Chronic stimulation of unexcised or microscopic rests or autotransplanted parathyroid tissue may cause these rests to function as autonomous glands or hyperplasia, making it difficult to achieve thesurgery.or.kr a physiologically acceptable condition in these patients.
With regard to recurrence or surgical failure due to the presence of autotransplanted parathyroid tissue, it would be helpful to identify the nodularity of the excised portion of the remnant parathyroid tissue by histopathologic examination [16] . Future use of the equation y = 6.755 ＋ (-0.054)x derived from the scatterplot (Fig. 4) may make it possible to predict the follow-up PTH level (y) for any given percentage reduction in ioPTH (x). This method may predict a successful operation.
In conclusion, ioPTH measurement can be a useful tool for improving the cure rate of operations for sHPT.
Because we chose 40 minutes (ioPTH3) as the optimal time for measuring PTH3 during the operation, we recommend using a criterion of ＞85% ioPTH decline at 40 minutes by ROC analysis. Patients with additional tissue removed would have an insufficient decline in PTH levels based on this criterion. Prospective analyses, including a cost-effectiveness study, are needed to validate this criterion.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
